11 results about "Nelumbo nucifera" patented technology

This invention relates to a high-necked fabric, its finishing process, and garments containing the high-necked fabric. The finishing process includes the following steps: drying and sieving washed leaves and branches of *Nelumbo nucifera* to obtain dried material; subjecting the dried material to pyrolysis treatment; cooling and grinding to obtain *Nelumbo nucifera* biochar; the raw materials for preparing the finishing reagent, by weight, include 15-25 parts of aqueous polyurethane emulsion, 6-12 parts of *Nelumbo nucifera* biochar, 4-8 parts of hydroxyl silicone oil, 1-3 parts of citric acid, 3-8 parts of nano-titanium dioxide, 2-5 parts of chitosan quaternary ammonium salt, 1-3 parts of silane coupling agent, 1-2 parts of fatty alcohol polyoxyethylene ether, 1-3 parts of sodium hexametaphosphate, 1-5 parts of acetic acid, and 50-60 parts of deionized water. The high-necked fabric of this invention has good abrasion resistance, waterproof performance, and antioxidant properties, and can be used for the collars or cuffs of down garments and sportswear, with broad market application prospects.

This invention belongs to the field of traditional Chinese medicine technology, and discloses a kidney-tonifying and turbidity-resolving traditional Chinese medicine compound, its preparation method, and its anti-atherosclerotic application. The effective components of the kidney-tonifying and turbidity-resolving traditional Chinese medicine compound, by mass, consist of 15 parts Rehmannia glutinosa (processed), 15 parts Astragalus membranaceus (raw), 9 parts Cistanche deserticola, 10 parts Nelumbo nucifera (lotus leaf), 20 parts Gynostemma pentaphyllum, 12 parts Crataegus pinnatifida, and 6 parts Citrus reticulata (dried tangerine peel). The preparation method of the kidney-tonifying and turbidity-resolving traditional Chinese medicine compound is simple, without any additives, and has strong pharmacological compatibility. The anti-atherosclerotic application of the kidney-tonifying and turbidity-resolving traditional Chinese medicine compound includes: including observation cases, grouping, measuring the CIMT value and plaque area of ​​the included cases, data processing, and result analysis. This invention's kidney-tonifying and turbidity-resolving traditional Chinese medicine intervention can reduce the CIMT value and carotid plaque area in patients with atherosclerosis, and has a significant anti-atherosclerotic effect.

The invention discloses a traditional Chinese medicine composition for treating infertility, which is prepared from the following raw materials: radix rehmanniae recen, radix paeoniae alba, turtle shell, cortex moutan, peach kernel, ginseng, radix glehniae, medlar, oyster, rhizoma cyperi, radix curcumae, astragalus membranaceus, angelica sinensis, rhizoma anemarrhenae, golden cypress, lotus seed, rhizoma atractylodis macrocephalae, pericarpium citri reticulatae, chicken's gizzard-membrane, radix bupleuri, tetrapanax papyriferus, donkey-hide gelatin, eucommia ulmoides and deer glue. Spleen tonifying, blood nourishing, phlegm reducing and dampness clearing; the effects of soothing liver-qi stagnation, promoting qi and activating blood are achieved; qi is benefited, blood is nourished, and Zhongzhou is promoted to regenerate Qi and blood; promoting blood circulation to remove blood stasis and dredging Chong and Ren qi; the traditional Chinese medicine composition has the effects of clearing heat, promoting diuresis, eliminating dampness and reducing phlegm, can achieve sufficient qi and blood of liver and kidney and smooth Chong and Ren channels, has a good treatment effect on male and female infertility caused by various reasons, and is particularly suitable for female infertility caused by kidney deficiency, weakness, fallopian tube blockage, cold uterus, kidney deficiency type ovulation disorder, obesity, stasis, weakness, blood deficiency and the like; and the traditional Chinese medicine composition is also suitable for male infertility caused by cold sperm, rare sperm, oligospermia and necrospermia due to kidney deficiency.

This invention relates to a decoction process and equipment for treating non-alcoholic fatty liver disease (NAFLD). The raw materials of the decoction, by weight, are: 15 parts Artemisia capillaris, 10 parts Gardenia jasminoides, 10 parts Crataegus pinnatifida, 10 parts Bupleurum chinense, 15 parts stir-fried Paeonia lactiflora, 10 parts Citrus aurantium, 5 parts Glycyrrhiza uralensis, 10 parts Nelumbo nucifera, 15 parts Cassia tora, 10 parts Gynostemma pentaphyllum, 30 parts Benincasa hispida peel, 15 parts Salvia miltiorrhiza, and 9 parts Atractylodes lancea. The equipment includes a decoction container and a container lid. A connecting column is provided on the lower surface of the container lid. A first medicine-carrying mesh tray is fixed at the bottom of the connecting column. A second medicine-carrying mesh tray is longitudinally hinged to each side of the first medicine-carrying mesh tray. A rotating sleeve is provided on the upper part of the connecting column. The rotating sleeve is connected to the outer side of the second medicine-carrying mesh tray through multiple stainless steel ropes. This invention transforms the traditional wisdom of batch decoction in traditional Chinese medicine into a standard process that can be executed by modern automated equipment, and provides a standardized decoction solution for the treatment of NAFLD with traditional Chinese medicine that is more effective, safer to use, and easier to operate.

The application discloses rhizosphere growth promoting bacteria Nn211 of Nelumbo nucifera and application thereof. The gibbsiella dentisursi Nn211 provided by the application is preserved in the China General Microbiological Culture Collection Center on November 4, 2022, and the preservation number is CGMCC No. 26047. The Nn211 strain has the characteristics of producing ACC deaminase, producing urease, secreting growth hormone IAA and tolerating high-concentration cadmium; the strain is inoculated into the rhizosphere of Nelumbo nucifera seedlings and adult plants, can effectively promote the growth of the Nelumbo nucifera seedlings and adult plants, and improve the stress resistance of the Nelumbo nucifera under cadmium stress; in addition, the strain can promote the absorption and enrichment of cadmium by the Nelumbo nucifera and reduce the cadmium content in the sediment environment. The application has important significance for the development of multifunctional microbial fertilizer (promoting plant growth and improving plant cadmium tolerance) and the remediation of cadmium-polluted environment.

This invention provides a fermented traditional Chinese medicine powder for women, which is related to the field of pharmaceutical technology. Based on dry weight, it is composed of the following raw materials: Astragalus membranaceus 15 parts, Citrus aurantium 9 parts, Polygonatum odoratum 9 parts, Angelica dahurica 6 parts, Longan aril 12 parts, Lilium brownii 6 parts, Lycium barbarum 12 parts, Poria cocos 9 parts, Nelumbo nucifera 9 parts, Lophatherum gracile 6 parts, Polygonatum sibiricum 15 parts, Morus alba 15 parts, Pueraria lobata 9 parts, Ziziphus jujuba var. spinosa 6 parts, Angelica sinensis 9 parts, Ganoderma lucidum 15 parts, and Ziziphus jujuba 9 parts. The powder is produced through solid-state fermentation with compound probiotics, low-temperature drying, ultra-fine pulverization, and irradiation sterilization. The fermented Chinese herbal powder for women, which is a formula for replenishing qi and blood, provided by this invention, solves the problems of poor targeting and insufficient precision in conditioning of existing tonifying medicines for women's physiological characteristics. It can effectively improve the sub-health state of women caused by insufficient qi and blood, deficiency of yin fluids, and restlessness, such as insomnia, dreaminess, sallow complexion, dull skin, fatigue, dizziness, and palpitations.

This invention belongs to the field of traditional Chinese medicine technology, specifically relating to a pharmaceutical composition for treating simple obesity of spleen deficiency and dampness retention type and its application. This pharmaceutical composition is prepared based on seven traditional Chinese medicines listed in the Food and Drug Catalogue: Codonopsis pilosula, Poria cocos, Coix lacryma-jobi, Dioscorea opposita, Nelumbo nucifera, Lilium brownii, and Ziziphus jujuba. The pharmaceutical composition provided by this invention improves the condition of swollen, pale, and white-coated tongue in rats with simple obesity of spleen deficiency and dampness retention type, and improves abnormal lipid metabolism; it can effectively regulate abnormalities in serum BUN, UA, MTL, VIP, and other indicators in rats with simple obesity of spleen deficiency and dampness retention type, improve gastrointestinal emptying, enhance gastrointestinal motility, and increase the calcium content of myocardial cell membranes. 2+ -ATPase, Na + -K + - It increases ATPase activity, improves cellular energy metabolism, and reduces the risk of cardiovascular disease caused by obesity; it inhibits the expression levels of BUN and UA, which can treat obesity-induced hyperuricemia and improve renal metabolism. It also exerts a therapeutic effect on simple obese rats with spleen deficiency and dampness retention.

The present invention is related to a skin care composition comprising (1) a physiologically acceptable medium and (2) a synergistic composition consisting of: a blend of a Nelumbo nucifera (Sacred Lotus) serum fraction and a Camellia sinensis (Tea) serum fraction in a respective weight ratio of 75:25; or a blend of a Nelumbo nucifera (Sacred Lotus) serum fraction and a Chamomilla recutita (German chamomile) serum fraction in a respective weight ratio of 75:25. The invention also relates to a method for improving skin appearance associated with skin aging comprising applying compositions thereof.

The invention discloses a traditional Chinese medicine fermentation composition for relieving insomnia and a preparation method thereof, and belongs to the technical field of traditional Chinese medicine preparations prepared through biological fermentation. The composition comprises semen ziziphi spinosae, radix astragali, poria cocos, fructus lycii, arillus longan, rhizoma polygonati, fructus ziziphi jujubae, mulberries, bulbus lilii, semen nelumbinis, colla corii asini and honey. The composition is prepared by mixing traditional Chinese medicines except donkey-hide gelatin and honey with donkey-hide gelatin after fermentation and extraction of composite strains, and the composite strains are composed of lactobacillus acidophilus CGMCC 1.1854, lactobacillus plantarum CGMCC 1.557 and bifidobacterium longum CGMCC 1.2186 according to the viable count ratio of 1: 1.5: 0.8. The composition takes qi and blood tonifying, heart calming and nerve soothing as the treatment principle, constructs a multi-organ synergistic tonifying system, has the advantages of treating both symptoms and root causes, being high in safety, wide in applicable crowd and the like, and is suitable for preventing and treating symptoms such as insomnia, weakness and fatigue syndrome.

The invention belongs to the technical field of medicinal and edible health-care food, and particularly relates to a medicinal and edible health-care composition capable of enhancing immunity and a preparation method of the medicinal and edible health-care composition. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 35-45 parts of ginseng, 30-40 parts of lucid ganoderma, 30-45 parts of cistanche, 65-75 parts of rhizoma polygonati, 40-50 parts of radix polygonati officinalis, 50-60 parts of poria cocos, 80-100 parts of Chinese yam, 50-60 parts of gordon euryale seed, 50-60 parts of lotus seed, 180-220 parts of soybean peptide, 12-18 parts of galangal, 6-12 parts of clove and 6-12 parts of nutmeg. According to the health-care composition taking the medicinal and edible raw materials and the soybean peptide as the core, the mixing problem is solved by virtue of a specific ratio and process synergy and by taking the soybean peptide as a structured carrier, the activity is kept after the tail section of volatile oil, warm tonifying and yin nourishing balance is realized, the immunity is stably improved, and the product stability and industrialization consistency are both considered.

The invention discloses a traditional Chinese medicine composition for treating Crohn disease intestinal fibrosis as well as a preparation method and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 6-18 parts of codonopsis pilosula, 6-18 parts of bighead atractylodes rhizome, 1-6 parts of coptis chinensis, 9-24 parts of Chinese yam, 9-24 parts of dahurian patrinia herb, 5-15 parts of rhizoma atractylodis, 5-15 parts of pericarpium citri reticulatae, 5-15 parts of lotus plumule, 9-24 parts of red paeony root, 9-24 parts of hairyvein agrimony, 5-15 parts of turtle shell, 5-15 parts of cassia twig, 9-24 parts of poria cocos, 6-18 parts of peach kernel, 5-15 parts of moutan bark, 5-15 parts of dendrobe, 5-15 parts of selaginella tamariscina and 12-30 parts of coix seed. Aiming at the clinical problem of fibrous stenosis formed after inflammation control, the traditional Chinese medicine composition disclosed by the invention adopts a treatment method of tonifying spleen and drying dampness, clearing heat and removing turbidity, promoting blood circulation to remove blood stasis and softening hardness to dissipate stagnation, and is scientific in formula. Network pharmacology prediction and experimental verification show that the compound can regulate and control the fibrosis process in a multi-target manner, remarkably reverse the formed intestinal fibrosis and improve the intestinal elasticity, is good in long-term medication safety, and provides an effective traditional Chinese medicine solution for treating the Crohn disease intestinal fibrosis.